Spots Global Cancer Trial Database for Pain After Endoscopic Submucosal Dissection

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Pain After Endoscopic Submucosal Dissection

Official Title: Pain After Endoscopic Submucosal Dissection

Study ID: NCT02254889

Conditions

Gastric Neoplasm

Interventions

proton pump inhibitor

Study Description

Brief Summary: Endoscopic submucosal dissection (ESD) is widely used for local treatment of gastric neoplasms. Although ESD-related complications such as bleeding and perforation have been reported, data is currently lacking on the development of pain, which is one of the most common adverse events after ESD. Therefore, in the present study, we investigated the incidence and clinicopathologic risk factors of pain after ESD.

Detailed Description: A prospective randomized controlled study was conducted evaluating 156 patients with gastric neoplasms treated by ESD at Gangnam Severance Hospital between April 2011 and December 2014. All subjects were randomly assigned to treatment with intravenous proton pump inhibitor (PPI) either before or after ESD.